SEC Form 5 · accession 0001140361-17-001897
SANGAMO THERAPEUTICS, INC · SGMO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Edward O Lanphier II
Director
Period of report
Dec 31, 2016
Accepted (ET)
Jan 13, 2017 · 4:47 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001001233
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Dec 12, 2016 | G | 30,000 | $0.00 | D | 1,252,119 | I | By Trust |
| Common CtockF3 | holding | — | — | — | 41,663 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The shares were transferred as a bona fide gift without consideration.
- F2These shares are held in the Edward O. Lanphier II and Cameron M. Lanphier Trust U/T/A August 30, 2002, Edward O. Lanphier II and Cameron M. Lanphier, Trustees.
- F3Consist of 41,666 shares subject to restricted stock units granted on December 8, 2015 that will be issued as such units vest in accordance with their terms.